Skip to content

Validation of the SightSave vision test

Validation of the SightSave contrast sensitivity application against standard logMAR constrast sensitivity charts

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN15358662
Enrollment
30
Registered
2023-02-07
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Testing of contrast sensitivity Eye Diseases

Interventions

Subjects will have their visual acuity measured using 4m logMAR visual acuity charts at contrast levels 1.25%, 2.5%, 5% ,10%, 25% and 100% and then use the SightSave contrast sensitivity app on a touc

Sponsors

ScottHealth Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Has visually significant cataract and listed for a cataract surgery with intraocular lens implant procedure 2. Patient consents to having contrast sensitivity testing on SightSave contrast sensitivity app and logMAR contrast sensitivity charts 3. Patient is able to use the logMAR charts and has capacity to read the letters

Exclusion criteria

Exclusion criteria: 1. Unable to use either or both, logMAR contrast sensitivity chart 2. Unable to read the chart letters

Design outcomes

Primary

MeasureTime frame
LogMAR visual acuity at contrast levels 1.25%, 2.5%, 5%,10%, 25% and 100% measured using 4m logMAR visual acuity charts and the SightSave contrast sensitivity app on a touchscreen device

Secondary

MeasureTime frame
At the end of the testing: 1. Time taken to complete each test 2. 5 point scale evaluation by the patient of the ease of testing for them

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026